{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T14:27:46Z","timestamp":1783002466218,"version":"3.54.5"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,1,3]]},"DOI":"10.7759\/cureus.51608","type":"journal-article","created":{"date-parts":[[2024,1,4]],"date-time":"2024-01-04T01:55:03Z","timestamp":1704333303000},"source":"Crossref","is-referenced-by-count":3,"title":["Benefits and Risks of Medications Used in the Management of Hypotension: A Review"],"prefix":"10.7759","author":[{"given":"Thangwaritorn","family":"Skylynn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Abel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee","family":"Christopher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghafary","family":"Suliman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rivera","family":"Dominic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Varughese","family":"Joel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeyu","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudhakar","family":"Pemminati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Hypotension","author":"Sharma S","year":"2023","unstructured":"Sharma S, Hashmi MF, Bhattacharya PT. Hypotension. StatPearls Publishing, Treasure Island, FL; 2023."},{"key":"ref2","article-title":"Hypotension: a clinical care review","volume":"39","author":"Saljoughian M","year":"2018","unstructured":"Saljoughian M. Hypotension: a clinical care review. US Pharm. 2018, 39:2-4.","journal-title":"US Pharm"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfh420","article-title":"Midodrine appears to be safe and effective for dialysis-induced hypotension: a systematic review","volume":"19","author":"Prakash S","year":"2004","unstructured":"Prakash S, Garg AX, Heidenheim AP, House AA. Midodrine appears to be safe and effective for dialysis-induced hypotension: a systematic review. Nephrol Dial Transplant. 2004, 19:2553-8. 10.1093\/ndt\/gfh420","journal-title":"Nephrol Dial Transplant"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1997.03540370036033","article-title":"Efficacy of midodrine vs placebo in neurogenic orthostatic hypotension. A randomized, double-blind multicenter study. Midodrine Study Group","volume":"277","author":"Low PA","year":"1997","unstructured":"Low PA, Gilden JL, Freeman R, Sheng KN, McElligott MA. Efficacy of midodrine vs placebo in neurogenic orthostatic hypotension. A randomized, double-blind multicenter study. Midodrine Study Group. JAMA. 1997, 277:1046-51. 10.1001\/jama.1997.03540370036033","journal-title":"JAMA"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1080\/10790268.2021.1977904","article-title":"Clinical trial of home blood pressure monitoring following midodrine administration in hypotensive individuals with spinal cord injury","volume":"46","author":"Wecht JM","year":"2023","unstructured":"Wecht JM, Weir JP, Katzelnick CG, Dyson-Hudson TA, Bauman WA, Kirshblum SC. Clinical trial of home blood pressure monitoring following midodrine administration in hypotensive individuals with spinal cord injury. J Spinal Cord Med. 2023, 46:531-9. 10.1080\/10790268.2021.1977904","journal-title":"J Spinal Cord Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s11916-003-0011-7","article-title":"Ergotamine and dihydroergotamine: a review","volume":"7","author":"Bigal ME","year":"2003","unstructured":"Bigal ME, Tepper SJ. Ergotamine and dihydroergotamine: a review. Curr Pain Headache Rep. 2003, 7:55-62. 10.1007\/s11916-003-0011-7","journal-title":"Curr Pain Headache Rep"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2014.00270","article-title":"Combination ergotamine and caffeine improves seated blood pressure and presyncopal symptoms in autonomic failure","volume":"5","author":"Arnold AC","year":"2014","unstructured":"Arnold AC, Ramirez CE, Choi L, et al.. Combination ergotamine and caffeine improves seated blood pressure and presyncopal symptoms in autonomic failure. Front Physiol. 2014, 5:270. 10.3389\/fphys.2014.00270","journal-title":"Front Physiol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2022.2131330","article-title":"A literature perspective on the pharmacological applications of yohimbine","volume":"54","author":"Jabir NR","year":"2022","unstructured":"Jabir NR, Firoz CK, Zughaibi TA, et al.. A literature perspective on the pharmacological applications of yohimbine. Ann Med. 2022, 54:2861-75. 10.1080\/07853890.2022.2131330","journal-title":"Ann Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1981.tb01863.x","article-title":"Favourable effects of yohimbine on clomipramine-induced orthostatic hypotension: a double-blind study","volume":"12","author":"Lecrubier Y","year":"1981","unstructured":"Lecrubier Y, Puech AJ, Des Lauriers A. Favourable effects of yohimbine on clomipramine-induced orthostatic hypotension: a double-blind study. Br J Clin Pharmacol. 1981, 12:90-3. 10.1111\/j.1365-2125.1981.tb01863.x","journal-title":"Br J Clin Pharmacol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.110.154898","article-title":"Comparative efficacy of yohimbine against pyridostigmine for the treatment of orthostatic hypotension in autonomic failure","volume":"56","author":"Shibao C","year":"2010","unstructured":"Shibao C, Okamoto LE, Gamboa A, et al.. Comparative efficacy of yohimbine against pyridostigmine for the treatment of orthostatic hypotension in autonomic failure. Hypertension. 2010, 56:847-51. 10.1161\/HYPERTENSIONAHA.110.154898","journal-title":"Hypertension"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000000615","article-title":"Droxidopa for neurogenic orthostatic hypotension: a randomized, placebo-controlled, phase 3 trial","volume":"83","author":"Kaufmann H","year":"2014","unstructured":"Kaufmann H, Freeman R, Biaggioni I, et al.. Droxidopa for neurogenic orthostatic hypotension: a randomized, placebo-controlled, phase 3 trial. Neurology. 2014, 83:328-35. 10.1212\/WNL.0000000000000615","journal-title":"Neurology"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/phar.1939","article-title":"Effect of inpatient dobutamine versus milrinone on out-of-hospital mortality in patients with acute decompensated heart failure","volume":"37","author":"King JB","year":"2017","unstructured":"King JB, Shah RU, Sainski-Nguyen A, Biskupiak J, Munger MA, Bress AP. Effect of inpatient dobutamine versus milrinone on out-of-hospital mortality in patients with acute decompensated heart failure. Pharmacotherapy. 2017, 37:662-72. 10.1002\/phar.1939","journal-title":"Pharmacotherapy"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/ijcp.14689","article-title":"The effect of dobutamine vs milrinone in sepsis: a big data, real-world study","volume":"75","author":"Zhu Y","year":"2021","unstructured":"Zhu Y, Yin H, Zhang R, Ye X, Wei J. The effect of dobutamine vs milrinone in sepsis: a big data, real-world study. Int J Clin Pract. 2021, 75:e14689. 10.1111\/ijcp.14689","journal-title":"Int J Clin Pract"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1067\/mpd.2002.120834","article-title":"Randomized trial of dobutamine versus dopamine in preterm infants with low systemic blood flow","volume":"140","author":"Osborn D","year":"2002","unstructured":"Osborn D, Evans N, Kluckow M. Randomized trial of dobutamine versus dopamine in preterm infants with low systemic blood flow. J Pediatr. 2002, 140:183-91. 10.1067\/mpd.2002.120834","journal-title":"J Pediatr"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1136\/adc.69.1_spec_no.59","article-title":"Response to dobutamine and dopamine in the hypotensive very preterm infant","volume":"69","author":"Roz\u00e9 JC","year":"1993","unstructured":"Roz\u00e9 JC, Tohier C, Maingueneau C, Lef\u00e8vre M, Mouzard A. Response to dobutamine and dopamine in the hypotensive very preterm infant. Arch Dis Child. 1993, 69:59-63. 10.1136\/adc.69.1_spec_no.59","journal-title":"Arch Dis Child"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.5152\/TJAR.2020.70","article-title":"Vasopressors for the treatment and prophylaxis of spinal induced hypotension during caesarean section","volume":"49","author":"Biricik E","year":"2021","unstructured":"Biricik E, \u00dcnl\u00fcgen\u00e7 H. Vasopressors for the treatment and prophylaxis of spinal induced hypotension during caesarean section. Turk J Anaesthesiol Reanim. 2021, 49:3-10. 10.5152\/TJAR.2020.70","journal-title":"Turk J Anaesthesiol Reanim"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.4103\/0970-9185.202183","article-title":"Comparing slow and rapid bolus of ephedrine in pregnant patients undergoing planned cesarean section under spinal anesthesia","volume":"33","author":"Gunasekaran P","year":"2017","unstructured":"Gunasekaran P, Elakkumanan LB, Balachander H, Satyaprakash MV. Comparing slow and rapid bolus of ephedrine in pregnant patients undergoing planned cesarean section under spinal anesthesia. J Anaesthesiol Clin Pharmacol. 2017, 33:92-6. 10.4103\/0970-9185.202183","journal-title":"J Anaesthesiol Clin Pharmacol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.4103\/0971-9784.74397","article-title":"Preoperative ephedrine counters hypotension with propofol anesthesia during valve surgery: a dose dependent study","volume":"14","author":"El-Tahan MR","year":"2011","unstructured":"El-Tahan MR. Preoperative ephedrine counters hypotension with propofol anesthesia during valve surgery: a dose dependent study. Ann Card Anaesth. 2011, 14:30-40. 10.4103\/0971-9784.74397","journal-title":"Ann Card Anaesth"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2017.00002","article-title":"Comparison of phenylephrine and ephedrine in treatment of spinal-induced hypotension in high-risk pregnancies: a narrative review","volume":"4","author":"Dusitkasem S","year":"2017","unstructured":"Dusitkasem S, Herndon BH, Somjit M, Stahl DL, Bitticker E, Coffman JC. Comparison of phenylephrine and ephedrine in treatment of spinal-induced hypotension in high-risk pregnancies: a narrative review. Front Med (Lausanne). 2017, 4:2. 10.3389\/fmed.2017.00002","journal-title":"Front Med (Lausanne)"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.accpm.2023.101204","article-title":"The use of epinephrine infusion for the prevention of spinal hypotension during caesarean delivery: a randomized controlled dose-finding trial","volume":"42","author":"Hasanin AM","year":"2023","unstructured":"Hasanin AM, Abou Amer A, Hassabelnaby YS, et al.. The use of epinephrine infusion for the prevention of spinal hypotension during caesarean delivery: a randomized controlled dose-finding trial. Anaesth Crit Care Pain Med. 2023, 42:101204. 10.1016\/j.accpm.2023.101204","journal-title":"Anaesth Crit Care Pain Med"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2020.08.004","article-title":"Comparison of continuous infusion of epinephrine and phenylephrine on hemodynamics during spinal anesthesia for cesarean delivery: a randomized controlled trial","volume":"42","author":"Wang YB","year":"2020","unstructured":"Wang YB, Yang ZY, Zhang WP. Comparison of continuous infusion of epinephrine and phenylephrine on hemodynamics during spinal anesthesia for cesarean delivery: a randomized controlled trial. Clin Ther. 2020, 42:2001-9. 10.1016\/j.clinthera.2020.08.004","journal-title":"Clin Ther"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1177\/20451253221092931","article-title":"Treatment strategies for clozapine-induced hypotension: a systematic review","volume":"12","author":"Tanzer TD","year":"2022","unstructured":"Tanzer TD, Brouard T, Pra SD, et al.. Treatment strategies for clozapine-induced hypotension: a systematic review. Ther Adv Psychopharmacol. 2022, 12:20451253221092931. 10.1177\/20451253221092931","journal-title":"Ther Adv Psychopharmacol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/7951025","article-title":"Comparison of dopamine and norepinephrine use for the treatment of hypotension in out-of-hospital cardiac arrest patients with return of spontaneous circulation","volume":"2020","author":"Li CJ","year":"2020","unstructured":"Li CJ, Wu KH, Chen CC, Law YY, Chuang PC, Chen YC. Comparison of dopamine and norepinephrine use for the treatment of hypotension in out-of-hospital cardiac arrest patients with return of spontaneous circulation. Emerg Med Int. 2020, 2020:7951025 . 10.1155\/2020\/7951025","journal-title":"Emerg Med Int"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0907118","article-title":"Comparison of dopamine and norepinephrine in the treatment of shock","volume":"362","author":"De Backer D","year":"2010","unstructured":"De Backer D, Biston P, Devriendt J, et al.. Comparison of dopamine and norepinephrine in the treatment of shock. N Engl J Med. 2010, 362:779-89. 10.1056\/NEJMoa0907118","journal-title":"N Engl J Med"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2014.12.027","article-title":"Vasopressin versus dopamine for treatment of hypotension in extremely low birth weight infants: a randomized, blinded pilot study","volume":"166","author":"Rios DR","year":"2015","unstructured":"Rios DR, Kaiser JR. Vasopressin versus dopamine for treatment of hypotension in extremely low birth weight infants: a randomized, blinded pilot study. J Pediatr. 2015, 166:850-5. 10.1016\/j.jpeds.2014.12.027","journal-title":"J Pediatr"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1111\/jch.13260","article-title":"Evaluating the effectiveness of atomoxetine for the treatment of primary orthostatic hypotension in adults","volume":"20","author":"Patel H","year":"2018","unstructured":"Patel H, Simpson A, Palevoda G, Hale GM. Evaluating the effectiveness of atomoxetine for the treatment of primary orthostatic hypotension in adults. J Clin Hypertens (Greenwich). 2018, 20:794-7. 10.1111\/jch.13260","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"ref27","article-title":"Fludrocortisone","author":"Rahman M","year":"2023","unstructured":"Rahman M, Anjum F. Fludrocortisone. StatPearls Publishing, Treasure Island, FL; 2023."},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1111\/ene.13260","article-title":"Pyridostigmine bromide versus fludrocortisone in the treatment of orthostatic hypotension in Parkinson's disease - a randomized controlled trial","volume":"24","author":"Schreglmann SR","year":"2017","unstructured":"Schreglmann SR, B\u00fcchele F, Sommerauer M, et al.. Pyridostigmine bromide versus fludrocortisone in the treatment of orthostatic hypotension in Parkinson's disease - a randomized controlled trial. Eur J Neurol. 2017, 24:545-51. 10.1111\/ene.13260","journal-title":"Eur J Neurol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.1.6014.872","article-title":"Therapeutic experience with fludrocortisone in diabetic postural hypotension","volume":"1","author":"Campbell IW","year":"1976","unstructured":"Campbell IW, Ewing DJ, Clarke BF. Therapeutic experience with fludrocortisone in diabetic postural hypotension. Br Med J. 1976, 1:872-4. 10.1136\/bmj.1.6014.872","journal-title":"Br Med J"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000004340","article-title":"Efficacy of single or combined midodrine and pyridostigmine in orthostatic hypotension","volume":"89","author":"Byun JI","year":"2017","unstructured":"Byun JI, Moon J, Kim DY, et al.. Efficacy of single or combined midodrine and pyridostigmine in orthostatic hypotension. Neurology. 2017, 89:1078-86. 10.1212\/WNL.0000000000004340","journal-title":"Neurology"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.63.4.noc50340","article-title":"Pyridostigmine treatment trial in neurogenic orthostatic hypotension","volume":"63","author":"Singer W","year":"2006","unstructured":"Singer W, Sandroni P, Opfer-Gehrking TL, et al.. Pyridostigmine treatment trial in neurogenic orthostatic hypotension. Arch Neurol. 2006, 63:513-8. 10.1001\/archneur.63.4.noc50340","journal-title":"Arch Neurol"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.118.11790","article-title":"Synergistic pressor effect of atomoxetine and pyridostigmine in patients with neurogenic orthostatic hypotension","volume":"73","author":"Okamoto LE","year":"2019","unstructured":"Okamoto LE, Shibao CA, Gamboa A, et al.. Synergistic pressor effect of atomoxetine and pyridostigmine in patients with neurogenic orthostatic hypotension. Hypertension. 2019, 73:235-41. 10.1161\/HYPERTENSIONAHA.118.11790","journal-title":"Hypertension"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1007\/s13311-018-0612-9","article-title":"Efficacy of propranolol, bisoprolol, and pyridostigmine for postural tachycardia syndrome: a randomized clinical trial","volume":"15","author":"Moon J","year":"2018","unstructured":"Moon J, Kim DY, Lee WJ, et al.. Efficacy of propranolol, bisoprolol, and pyridostigmine for postural tachycardia syndrome: a randomized clinical trial. Neurotherapeutics. 2018, 15:785-95. 10.1007\/s13311-018-0612-9","journal-title":"Neurotherapeutics"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1042\/cs0890367","article-title":"Effect of the somatostatin analogue, octreotide, on exercise-induced hypotension in human subjects with chronic sympathetic failure","volume":"89","author":"Smith GD","year":"1995","unstructured":"Smith GD, Alam M, Watson LP, Mathias CJ. Effect of the somatostatin analogue, octreotide, on exercise-induced hypotension in human subjects with chronic sympathetic failure. Clin Sci (Lond). 1995, 89:367-73. 10.1042\/cs0890367","journal-title":"Clin Sci (Lond)"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1999.00583.x","article-title":"Long-term haemodynamic effects of octreotide on postprandial splanchnic hyperemia in humans: a placebo-controlled echo-doppler study","volume":"13","author":"Ludwig D","year":"1999","unstructured":"Ludwig D, Terai S, Br\u00fcning A, Stange EF. Long-term haemodynamic effects of octreotide on postprandial splanchnic hyperemia in humans: a placebo-controlled echo-doppler study. Aliment Pharmacol Ther. 1999, 13:1119-29. 10.1046\/j.1365-2036.1999.00583.x","journal-title":"Aliment Pharmacol Ther"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1097\/00002826-199502000-00012","article-title":"Octreotide effects on orthostatic hypotension in patients with multiple system atrophy: a controlled study of acute administration","volume":"18","author":"Bordet R","year":"1995","unstructured":"Bordet R, Benhadjali J, Dest\u00e9e A, Belabbas A, Libersa C. Octreotide effects on orthostatic hypotension in patients with multiple system atrophy: a controlled study of acute administration. Clin Neuropharmacol. 1995, 18:83-9. 10.1097\/00002826-199502000-00012","journal-title":"Clin Neuropharmacol"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1007\/s10286-007-0436-x","article-title":"Treatment of autonomic neuropathy, postural tachycardia and orthostatic syncope with octreotide LAR","volume":"17","author":"Hoeldtke RD","year":"2007","unstructured":"Hoeldtke RD, Bryner KD, Hoeldtke ME, Hobbs G. Treatment of autonomic neuropathy, postural tachycardia and orthostatic syncope with octreotide LAR. Clin Auton Res. 2007, 17:334-40. 10.1007\/s10286-007-0436-x","journal-title":"Clin Auton Res"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.107.091355","article-title":"Acarbose, an alpha-glucosidase inhibitor, attenuates postprandial hypotension in autonomic failure","volume":"50","author":"Shibao C","year":"2007","unstructured":"Shibao C, Gamboa A, Diedrich A, Dossett C, Choi L, Farley G, Biaggioni I. Acarbose, an alpha-glucosidase inhibitor, attenuates postprandial hypotension in autonomic failure. Hypertension. 2007, 50:54-61. 10.1161\/HYPERTENSIONAHA.107.091355","journal-title":"Hypertension"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.2147\/DMSO.S28340","article-title":"Critical evaluation of the role of acarbose in the treatment of diabetes: patient considerations","volume":"5","author":"Rosak C","year":"2012","unstructured":"Rosak C, Mertes G. Critical evaluation of the role of acarbose in the treatment of diabetes: patient considerations. Diabetes Metab Syndr Obes. 2012, 5:357-67. 10.2147\/DMSO.S28340","journal-title":"Diabetes Metab Syndr Obes"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1038\/newbio231232a0","article-title":"Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs","volume":"231","author":"Vane JR","year":"1971","unstructured":"Vane JR. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat New Biol. 1971, 231:232-5. 10.1038\/newbio231232a0","journal-title":"Nat New Biol"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.5435\/00124635-200407000-00003","article-title":"Analgesic pharmacology: II. Specific analgesics","volume":"12","author":"Phillips WJ","year":"2004","unstructured":"Phillips WJ, Currier BL. Analgesic pharmacology: II. Specific analgesics. J Am Acad Orthop Surg. 2004, 12:221-33. 10.5435\/00124635-200407000-00003","journal-title":"J Am Acad Orthop Surg"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1097\/TA.0000000000000755","article-title":"Nonopioid management of acute pain associated with trauma: focus on pharmacologic options","volume":"79","author":"Oyler DR","year":"2015","unstructured":"Oyler DR, Parli SE, Bernard AC, Chang PK, Procter LD, Harned ME. Nonopioid management of acute pain associated with trauma: focus on pharmacologic options. J Trauma Acute Care Surg. 2015, 79:475-83. 10.1097\/TA.0000000000000755","journal-title":"J Trauma Acute Care Surg"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1016\/s0002-9343(99)00113-8","article-title":"Nephrotoxicity of nonsteroidal anti-inflammatory drugs: physiologic foundations and clinical implications","volume":"106","author":"Whelton A","year":"1999","unstructured":"Whelton A. Nephrotoxicity of nonsteroidal anti-inflammatory drugs: physiologic foundations and clinical implications. Am J Med. 1999, 106:13S-24S. 10.1016\/s0002-9343(99)00113-8","journal-title":"Am J Med"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.18433\/j3vw2f","article-title":"Adverse effects of nonsteroidal antiinflammatory drugs: an update of gastrointestinal, cardiovascular and renal complications","volume":"16","author":"Harirforoosh S","year":"2013","unstructured":"Harirforoosh S, Asghar W, Jamali F. Adverse effects of nonsteroidal antiinflammatory drugs: an update of gastrointestinal, cardiovascular and renal complications. J Pharm Pharm Sci. 2013, 16:821-47. 10.18433\/j3vw2f","journal-title":"J Pharm Pharm Sci"},{"key":"ref45","article-title":"Nonsteroidal Anti-inflammatory Drugs","author":"Ghlichloo I","year":"2023","unstructured":"Ghlichloo I, Gerriets V. Nonsteroidal Anti-inflammatory Drugs. StatPearls Publishing, Treasure Island, FL; 2023."},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1155\/2010\/834060","article-title":"Caffeine's vascular mechanisms of action","volume":"2010","author":"Echeverri D","year":"2010","unstructured":"Echeverri D, Montes FR, Cabrera M, Gal\u00e1n A, Prieto A. Caffeine's vascular mechanisms of action. Int J Vasc Med. 2010, 2010:834060. 10.1155\/2010\/834060","journal-title":"Int J Vasc Med"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2012.12.023","article-title":"Caffeine reduces myocardial blood flow during exercise","volume":"126","author":"Higgins JP","year":"2013","unstructured":"Higgins JP, Babu KM. Caffeine reduces myocardial blood flow during exercise. Am J Med. 2013, 126:730.e1-8. 10.1016\/j.amjmed.2012.12.023","journal-title":"Am J Med"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1989.00390030105020","article-title":"The effect of caffeine on ventricular ectopic activity in patients with malignant ventricular arrhythmia","volume":"149","author":"Graboys TB","year":"1989","unstructured":"Graboys TB, Blatt CM, Lown B. The effect of caffeine on ventricular ectopic activity in patients with malignant ventricular arrhythmia. Arch Intern Med. 1989, 149:637-9. 10.1001\/archinte.1989.00390030105020","journal-title":"Arch Intern Med"},{"key":"ref49","article-title":"Insights into the mechanisms of action of the MAO inhibitors phenelzine and tranylcypromine: a review","volume":"17","author":"Baker GB","year":"1992","unstructured":"Baker GB, Coutts RT, McKenna KF, Sherry-McKenna RL. Insights into the mechanisms of action of the MAO inhibitors phenelzine and tranylcypromine: a review. J Psychiatry Neurosci. 1992, 17:206-14.","journal-title":"J Psychiatry Neurosci"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.4088\/PCC.13r01515","article-title":"Reducing the burden of difficult-to-treat major depressive disorder: revisiting monoamine oxidase inhibitor therapy","volume":"15","author":"Culpepper L","year":"2013","unstructured":"Culpepper L. Reducing the burden of difficult-to-treat major depressive disorder: revisiting monoamine oxidase inhibitor therapy. Prim Care Companion CNS Disord. 2013, 15:PCC.13r01515. 10.4088\/PCC.13r01515","journal-title":"Prim Care Companion CNS Disord"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1212\/CON.0000000000000348","article-title":"Diagnostic approach to atypical Parkinsonian syndromes","volume":"22","author":"McFarland NR","year":"2016","unstructured":"McFarland NR. Diagnostic approach to atypical Parkinsonian syndromes. Continuum (Minneap Minn). 2016, 22:1117-42. 10.1212\/CON.0000000000000348","journal-title":"Continuum (Minneap Minn)"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1097\/00131746-200407000-00005","article-title":"The role of monoamine oxidase inhibitors in current psychiatric practice","volume":"10","author":"Fiedorowicz JG","year":"2004","unstructured":"Fiedorowicz JG, Swartz KL. The role of monoamine oxidase inhibitors in current psychiatric practice. J Psychiatr Pract. 2004, 10:239-48. 10.1097\/00131746-200407000-00005","journal-title":"J Psychiatr Pract"},{"key":"ref53","article-title":"Dietary restrictions and drug interactions with monoamine oxidase inhibitors: the state of the art","volume":"68 Suppl 8","author":"Rapaport MH","year":"2007","unstructured":"Rapaport MH. Dietary restrictions and drug interactions with monoamine oxidase inhibitors: the state of the art. J Clin Psychiatry. 2007, 68 Suppl 8:42-6.","journal-title":"J Clin Psychiatry"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.11096su1c.03","article-title":"Dietary restrictions and drug interactions with monoamine oxidase inhibitors: an update","volume":"73 Suppl 1","author":"Flockhart DA","year":"2012","unstructured":"Flockhart DA. Dietary restrictions and drug interactions with monoamine oxidase inhibitors: an update. J Clin Psychiatry. 2012, 73 Suppl 1:17-24. 10.4088\/JCP.11096su1c.03","journal-title":"J Clin Psychiatry"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/219487-benefits-and-risks-of-medications-used-in-the-management-of-hypotension-a-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:13:24Z","timestamp":1707509604000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/219487-benefits-and-risks-of-medications-used-in-the-management-of-hypotension-a-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,3]]},"references-count":54,"URL":"https:\/\/doi.org\/10.7759\/cureus.51608","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1,3]]}}}